{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Stephen Ubl, who became head of the Pharmaceutical Research and Manufacturers of America late last year, is facing rising criticism of the industry.", "headline": {"main": "Top Lobbyist for Drug Makers Threads a Thicket of Outrage", "print_headline": "Lobbying for Drug Makers, and Fending Off Anger Over Prices"}, "abstract": null, "print_page": "1", "word_count": "1401", "_id": "56d08f25798810250878593f", "snippet": "Stephen Ubl, who became head of the Pharmaceutical Research and Manufacturers of America late last year, is facing rising criticism of the industry.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2016/02/27/business/top-pharmaceutical-lobbyist-threads-a-thicket-of-outrage.html", "multimedia": [{"subtype": "wide", "url": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-articleLarge.jpg", "height": 421, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-articleLarge.jpg", "xlargeheight": "421"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Ubl, Stephen J (1969- )", "is_major": "Y", "rank": "1", "name": "persons"}, {"value": "Pharmaceutical Research and Manufacturers of America", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Lobbying and Lobbyists", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2016-02-27T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Life and disability insurers sometimes set higher rates for women who suffer depression after childbirth, or decline coverage at all.", "headline": {"main": "An Insurance Penalty From Postpartum Depression", "kicker": "Your Money", "print_headline": "A Postpartum Penalty", "content_kicker": "Your Money"}, "abstract": null, "print_page": "1", "word_count": "1428", "_id": "56d02238798810653329f672", "snippet": "Life and disability insurers sometimes set higher rates for women who suffer depression after childbirth, or decline coverage at all.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2016/02/27/your-money/an-insurance-penalty-from-postpartum-depression.html", "multimedia": [{"subtype": "wide", "url": "images/2016/02/26/business/27money/27money-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2016/02/26/business/27money/27money-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2016/02/26/business/27money/27money-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2016/02/26/business/27money/27money-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2016/02/26/business/27money/27money-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2016/02/26/business/27money/27money-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Depression (Mental)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Life Insurance", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Pregnancy and Childbirth", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Disability Insurance", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Ron", "lastname": "LIEBER"}], "original": "By RON LIEBER"}, "document_type": "article", "pub_date": "2016-02-27T00:00:00Z", "section_name": "Your Money"}, {"type_of_material": "News", "blog": [], "news_desk": "Upshot", "lead_paragraph": "Getting the incentives right for new uses can give us more safety and more value for our health care dollar.", "headline": {"main": "How to Make the Most of Drugs We Already Have", "content_kicker": "The New Health Care"}, "abstract": null, "print_page": null, "word_count": "934", "_id": "56caf6757988100e95e4416d", "snippet": "Getting the incentives right for new uses can give us more safety and more value for our health care dollar.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2016/02/23/upshot/drugs-fda.html", "multimedia": [{"subtype": "wide", "url": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Inventions and Patents", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Labeling and Labels (Product)", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Austin", "lastname": "FRAKT"}], "original": "By AUSTIN FRAKT"}, "document_type": "article", "pub_date": "2016-02-23T00:00:00Z", "section_name": "The Upshot"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "What if malignant cells, rather than dying with their host, had the ability to travel from body to body, evolving ever-deadlier skills along the way?", "headline": {"main": "Scientists Ponder the Prospect of Contagious Cancer", "kicker": "Raw Data", "print_headline": "Scientists Ponder Contagious Cancer", "content_kicker": "Raw Data"}, "abstract": "Studies suggest emergence of contagious human cancer is within realm of medical possibility, raising concern among researchers; cancerous cells have been known to pass among hosts in animal kingdom.", "print_page": "3", "word_count": "1014", "_id": "56caeaf97988100e95e44152", "snippet": "What if malignant cells, rather than dying with their host, had the ability to travel from body to body, evolving ever-deadlier skills along the way?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2016/02/23/science/scientists-ponder-the-prospect-of-contagious-cancer.html", "multimedia": [{"subtype": "wide", "url": "images/2016/02/23/science/23JOHNSON/23JOHNSON-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2016/02/23/science/23JOHNSON/23JOHNSON-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2016/02/23/science/23JOHNSON/23JOHNSON-articleLarge.jpg", "height": 704, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2016/02/23/science/23JOHNSON/23JOHNSON-articleLarge.jpg", "xlargeheight": "704"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2016/02/23/science/23JOHNSON/23JOHNSON-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2016/02/23/science/23JOHNSON/23JOHNSON-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Cancer", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Immune System", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Tumors", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "George", "lastname": "JOHNSON"}], "original": "By GEORGE JOHNSON"}, "document_type": "article", "pub_date": "2016-02-23T00:00:00Z", "section_name": "Science"}], "meta": {"hits": 4, "offset": 0, "time": 27}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}